# US 2024/0116981 A1 · Traceless reductively cleavable linker molecules for peptide purification

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0116981 A1
- Document ID: US20240116981A1
- Status: Published application
- Kind: A1
- Application number: 18/321,803
- Filed: 2023-05-23
- Published: 2024-04-11
- Earliest claimed: 2018-08-27
- Assignees: Belyntic GmbH
- Applicants: Belyntic GmbH
- Inventors: Robert ZITTERBART; Oliver REIMANN
- Web page: https://patentgrep.com/patent/US20240116981A1

## CPC

- C07K 1/22: Affinity chromatography or related techniques based upon selective absorption processes
- C07C 247/18: being further substituted by carboxyl groups
- C07C 271/08: having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C 271/20: to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
- C07C 323/63: the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07D 209/48: with oxygen atoms in positions 1 and 3, e.g. phthalimide
- C07D 213/56: Amides
- C07D 213/66: having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
- C07D 213/71: to which a second hetero atom is attached
- C07D 213/74: Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- C07D 213/75: Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- C07D 213/76: to which a second hetero atom is attached (nitro radicals C07D213/61)
- C07D 213/77: Hydrazine radicals
- C07D 213/82: in position 3
- C07D 233/64: with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C07D 237/08: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 239/26: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 239/42: One nitrogen atom (nitro radicals C07D239/30)
- C07D 285/01: Five-membered rings
- C07D 295/185: from aliphatic carboxylic acids
- C07D 417/04: directly linked by a ring-member-to-ring-member bond
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention relates to linker molecules of formula (1), X-Tb-Va-U-Y-Z (1) and a method for purifying peptides using said linker molecules. The linker molecule can be coupled to a purification resin via the moiety X and to a peptide via the moiety Y under the release of the leaving group Z. T is an optional spacer moiety and V is an optional electron withdrawing moiety. U is an aryl or 5- or 6-membered heteroaryl moiety bound to at least one electron withdrawing moiety V, W or E. The linker is stable under acidic conditions and releases the peptide upon addition of a reducing agent.

## Claims

### Claim 1

A compound of formula 1, X-Tb-Va-U-Y-Z (1), wherein
X is selected from a group consisting of a moiety of formula 2, 2a, 3, 3a and 4,
wherein
each R1 and R2 is independently from each other H or B, wherein at least R1 or R2 is B,
R3 is H or B,
R4 is H, C1-C12-alkyl or aryl, wherein the aldehyde or keto group may be protected by an acid labile protecting group,
B is an acid labile amine protecting group,
T is a linear or branched spacer comprising 1 to 5 of the moieties selected from: —C1-12-alkyl-, (—C2H4O—)1-12, —C(═O)—, —C(═O)—JR9—, —JR9—C(═O)—, —JR9—, phenyl, 5- or 6-membered heteroaryl,
J is CH or N,
and wherein
R9 is selected from the group consisting of H, C1-4-alkyl, —C1-6-alkyl-NH2, —C1-6-alkyl-NHB, —C1-6-alkyl-NB2, —R15, —C1-6-alkyl-R15, and —C1-6-alkyl-NH—R15, wherein
B is an independently selected acid labile amine protecting group,
R15 is a blocking agent that is able to react with an aldehyde moietyselected from the group consisting of cysteinyl, threoninyl, 2-mercaptoethanol, cysteamine, ethandithiole, hydroxylamine, O-methylhydroxylamine, N-methylhydroxylamine, dithiothreitol, and hydrazine, wherein:
amine and/or thiol moieties of the blocking agent may be protected by an acid labile amine protecting group B, and/or an acid labile thiol protecting group,
b is 0 or 1,
V is an electron-withdrawing moiety selected from the group consisting of —NR11—C(═O)—, —C(═O)—NR11—, —S(═O)—, —NR12—(CH2)p—, -piperazinyl-(CH2)p—, -pyridinyl-, and pyrimidinyl,
wherein
R11 is selected from the group consisting of H and C1-4-alkyl,
R12 is selected from the group consisting of H and C1-4-alkyl,
p is 0, 1 or 2,
a is 1, wherein the sum of a and b is 1 or 2,
U is a phenyl or a five- or six-membered heteroaryl moiety, that is bound to at least one of the moieties V, Wq and En and that is unsubstituted or substituted by C1-6alkyl, wherein
V is defined as described above,
W is selected from the group consisting of —N3, —NO2, —S(═O)—R8, —S—S—R8, —O—CH2—N3, —O—C(═O)—O—CH2—N3, —N═N-phenyl, —N═N—R8,
wherein
R8 is pyridyl, pyrimidinyl, pyrazinyl, pyridazyl, —C1-C6-alkyl or —(CH2)p—NMe2, p is 1, 2, 3 or 4,
E is an electron withdrawing group under acidic conditions,
n is an integer between 0 and 4, and q is an integer between 1 and 4, wherein the sum of n and q is equal or lower than 4, and wherein
when U is a phenyl moiety and Y is —(CH2)m—O—C(═O)—, the sum of Hammett constants of V, W, E under acidic conditions is larger than 0.45, and wherein
W is in ortho or para position in relation to Y,
Y is —(CH2)m—C(═O)— or —(CH2)m—O—C(═O)—, m is 1, 2 or 3, and
Z is an electron-withdrawing leaving group.

### Claim 2 (depends on 1)

The compound of claim 1, wherein E is selected from the group consisting of piperidinyl, piperazinyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazyl, —N(C2H4)2NH2, —N(C2H4)2N—B, —N═N-phenyl, —═N—R8, —(CH2)r—NH—C1-6alkyl, —(CH2)r—N(C1-6alkyl)2—, —F, —Cl, —Br, —I, —CN, —NO2, —N3, —CF3, —SO3H, —CO2H, —C(═O)NH2, —SO2Me, —SOMe, —SO2Et, —SOEt,
R8 is pyridyl, pyrimidinyl, pyrazinyl, pyridazyl, —C1-C6-alkyl or —(CH2)p—NMe2, and
B is an acid labile amine protecting group, and
r is 0, 1, 2, 3 or 4, particularly 0, 1 or 2.

### Claim 3 (depends on 1)

The compound according to claim 1, wherein,
B is selected from the group consisting of: Boc (—C(═O)OtBu), Eei (═CMeOEt, 1-ethoxyethylidene) trityl (—C(Ph)3), —C(═O)CPh3, Mmt (—C(Ph)2C6H4OMe), DMT (—C(Ph)(C6H4OMe)2), Cbz (—C(═O)OCH2Ph), benzylideneamine (═CPh), phtalimides (═(CO)2C6H4), p-toluenesulfonamides (—SO2C6H4Me), benzylamine (—CH2Ph), acetamides (—COMe), trifluoroacetamide (—COCF3), Dde (1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-ethyl) and 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl (ivDde), and the
acetal- or ketal protecting groups are selected from:
wherein r is 0 to 12, and
R10 is —C1-C12-alkyl-.

### Claim 4 (depends on 1)

The compound according to claim 1, wherein b is 1, and T is selected from the group consisting of:
—C1-C12-alkyl-, —R5—C(═O)—, —R5—C(═O)—NR9—, —R5—NR9—C(═O)—R6—, —R5—C(═O)—NR9—R6—, —R5—C(═O)—NR9—R5′—NR9′C(═O)—R6—, -and R5—C(═O)—NR9— wherein
R5, R5′ and R6 are independently from each other selected from the group consisting of C1-C12-alkyl and (—C2H4O—)1-12, and wherein,
R9 and R9′ are independently from each other selected from the group consisting of H, C1-4-alkyl, —C1-6alkyl-NH2, —C1-6-alkyl-NHB, —C1-6-alkyl-NB2, —R15, —C1-6alkyl-R15, and —C1-6-alkyl-NH—R15.

### Claim 5 (depends on 1)

The compound according to claim 1, wherein U is a five- or six-membered heteroaryl moiety comprising 1 or 2 heteroatoms.

### Claim 6 (depends on 1)

The compound according to claim 1, wherein U is selected from a group consisting of a moiety of formula 5, 6, 7 and 8,
wherein
when U is a moiety of formula 5 and 6, U is bound to T or V,
when U is a moiety of formula 7 and 8, U is bound to V,
A1, A2, A3, A4 and D1, D2, D3, D4 are independently from each other selected from the group consisting of C, N, S and O, wherein 2 to 4 of A1, A2, A3 and A4 or of D1, D2, D3 and D4 are C,
n is
an integer between 0 and 3, when U is a moiety of formula 5 or 6,
an integer between 0 and 4, when U is a moiety of formula 7 or 8,
q is an integer between 0 and 4, and wherein the sum of n and q is equal to or lower than 4.

### Claim 7 (depends on 6)

The compound according to claim 6, wherein U is selected from a group consisting of a moiety of formula 9, 10, 11 and 12,
wherein
U is bound to T or V when U is a moiety of formula 9 or 10,
U is bound to V when U is a moiety of formula 11 or 12,
A2, A3 and A4 are C, or two of A2, A3 and A4 are C and the other two of A2, A3 and A4 are N, and
D2 is C or N.

### Claim 8 (depends on 1)

The compound according to any claim 1, wherein U is selected from a group consisting of a moiety of formula 13, 14, 15, 16, 17,18, 19, 20 and 21,
wherein
U is bound to T or V when U is a moiety of formula 13, 14 or 15,
U is bound to V when U is a moiety of formula 16, 17 or 18,
A2, A3 and A4 is C or N, and
D2 is C or N.

### Claim 9 (depends on 1)

The compound according to claim 1 wherein Z is selected from the group consisting of: —F, —Cl, —Br, —I, —N3, —OH, —O(C═O)CH2(C═O)OH, —SR14, —OCF3, —OCH2CF3, —OSO2CF3, —SO2C6H4CH3, —SO2CF3, —SO2CH3,
wherein R14 is an C1-C6-alkyl-, an arylic- or benzylic substituent.

### Claim 10 (depends on 1)

A method for purifying peptides comprising the steps of
providing a crude linker-modified peptide, wherein the crude peptide is covalently bound to a linker molecule according to claim 1,
in a coupling step, coupling the linker-modified peptide with a solid support yielding an immobilized linker-modified peptide,
in a releasing step, releasing the peptide, in particular by adding a reducing agent under acidic conditions.

### Claim 11 (depends on 10)

The method according to claim 10, wherein in the releasing step, a reduced intermediate characterized by a reduced linker moiety of the immobilized linker-modified peptide is achieved and the peptide is released from said reduced intermediate by a change in temperature, or a change in pH.

### Claim 12 (depends on 10)

The method according to claim 10, wherein the linker-modified peptide is additionally bound to a synthesis resin and the synthesis resin is cleaved off before the coupling step is performed.

### Claim 13 (depends on 1, 10)

The method according to claim 10, wherein the linker molecule according to claim 1 comprises a moiety W and/or E that comprises an azide moiety.

### Claim 14 (depends on 10)

The method according to claim 10, wherein non-reacted aldehyde moieties of the solid support are blocked using a blocking agent after performing the coupling step.

### Claim 15 (depends on 10)

The method according to claim 10, wherein the reducing agent is selected from the group consisting of: triphenylphosphine, trimethylphosphine, triethylphosphine, tributylphosphine or tris(2-carboxyethyl)phosphine, trimethyl phosphite, triethyl phosphite, tributyl phosphine, diethyl phosphite, 5,5′-Dithiobis(2-nitrobenzoic acid), sodium dithionite (Na2S2O4), ethanedithiol, propanedithiol, dithioerythritol, dithiothreitol, Na2S, NaSH, glutathione, 2,2′-dithiodipyridine, BH3, 4,4,5,5-tetramethyl-1,3,2-dioxaborolane, catechol borane, borane tetrahydrofuran, borane dimethyl sulfide, borane dimethylamine complex, borane triphenylphosphine complex, borane tert-butylamine, LiAlH4, LiBH4, NaBH4, NaBH3CN, NaBH(OMe)3, NaBH(OCCH3)3, LiAlH(OCMe3)3, hydroquinone, sodium ascorbate, ascorbic acid, ascorbic acid with Kl, hydrazine, NH═NH, and formaldehyde.

### Claim 16 (depends on 1)

The compound according to claim 1 wherein V is an electron-withdrawing moiety selected from the group consisting of: —NR11—C(═O)—, —C(═O)—NR11—, —NR12—(CH2)p—, and -piperazinyl-(CH2)p.

### Claim 17 (depends on 1)

The compound according to claim 1 wherein b is 1, and T is —C1-C12-alkyl-, C1-3-alkyl, —R5—C(═O)—, —R5—C(═O)—NR9—R6—, —R5—C(═O)—NR9—, —C(═O)—NR9—R6—, —R5—NR9—C(═O)—R6—, —R5—NR9—R5′—NR9′C(═O)—R6—, —R5—C(═O)—NR9—R5′—NR9′—C(═O)—R6—, —R5—NR9—, —R5—NR9—R6—, —R5—NR9—R5′—NR9′—R6—, —R5—C(═O)—NR9—R5′—NR9′—R6—, —R5—C(═O)—O—R6—, —C(═O)—O—R6—, —R5-phenyl-R6—, —R5-phenyl-, -phenyl-R6—, -phenyl-, —R5-pyrroyl, —R5-pyrazoyl, —R5-imidazoyl, R5-piperazinyl-, —R5-pyridinyl, —R5-pyrimidinyl, —R5-pyrazinyl, —R5-pyridazinyl, —R5-pyrroyl-R6—, —R5-pyrazoyl-R6—, —R5-imidazoyl-R6—, —R5-piperazinyl-R6—, —R5-pyridinyl-R6—, —R5-pyrimidinyl-R6—, —R5-pyrazinyl-R6—, —R5-pyridazinyl-R6—, pyrroyl-R6—, pyrazoyl-R6—, imidazoyl-R6-piparazinyl-R6—, pyridinyl-R6—, pyrimidinyl-R6—, pyrazinyl-R6—, pyridazinyl-R6—, pyrroyl, pyrazoyl, imidazoyl, piperazinyl, pyridinyl, pyrimidinyl, pyrazinyl and pyridazinyl, wherein
R5, R5′ and R6 are independently from each other selected from the group consisting of C1-C12-alkyl and (—C2H4O—)1-12, and wherein,
R9 and R9′ are independently from each other selected from the group consisting of H, C1-4-alkyl, —C1-6alkyl-NH2, —C1-6-alkyl-NHB, —C1-6-alkyl-NB2, —R15, —C1-6alkyl-R15, and —C1-6-alkyl-NH—R15.

### Claim 18 (depends on 4)

The compound according to claim 4 wherein b is 1, T is selected from the group consisting of C1-3-alkyl, —R5—C(═O)—NR9—, and —R5—NR9—C(═O)—R6—.

### Claim 19 (depends on 8)

The compound according to claim 8 wherein U is a moiety of formula 15 or 19.

### Claim 20 (depends on 1)

The compound according to claim 1 wherein V is -pyridinyl- or -pyrimidinyl-.
